WhatsApp Skip to main content

Dr. Harsh J Shah

Bile Duct Cancer: What Is New in Treatment?

Last updated: 21-Nov-2026

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Dr Harsh Shah, liver cancer surgeon, Ahmedabad

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Liver Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience

In short

The biggest changes are tests that read the tumour’s own genes, targeted tablets for some of those changes, and an immune medicine added to chemotherapy.

Surgery is still the only way to remove the cancer for good. The new medicines help when it cannot be removed or comes back.

Several ideas, such as chemotherapy before surgery and blood DNA tests, are still being tested and are not routine.

For the complete picture of this cancer, from tests to surgery and medicines, read our biliary tract cancer treatment page. This post answers one question: what is new, and what is still only a trial.

What has really changed in recent years?

Three things: tumour gene tests, targeted tablets for some tumours, and an immune medicine given with chemotherapy. Surgery itself has not been replaced.

Bile duct and gallbladder cancers are together called biliary tract cancers. For many years the choices were surgery when possible, then chemotherapy. That is still the base. What is new is that doctors can now read the genes of a tumour and match a medicine to it, and that a second kind of medicine can be added to the usual chemotherapy.

What is new, and how firm the evidence is
ChangeWho it is forWhere it stands
Immune medicine added to gemcitabine and cisplatinCancer that cannot be removed, or has returnedNow part of usual care
Targeted tablets for a gene change such as FGFR2 or IDH1Those whose tumour test shows that change, mostly inside the liverUsed after first chemotherapy
Medicines for HER2-positive tumoursMainly gallbladder and bile duct tumours with high HER2In use in some countries; access in India varies
Chemotherapy before surgery for large gallbladder cancerTumours that look hard to removeUnder trial
Blood tests for tumour DNAAfter surgery, to judge the risk of returnUnder study, not for routine use

Why is a tumour test now so important?

Because the result can open a targeted tablet that works better than chemotherapy for that tumour. The test must be asked for early, on the first tissue.

Tumour cells carry changes in their genes. In biliary cancer a few of these changes have a matching medicine. The test is done on the tissue from a biopsy or an operation. The report is read by a cancer doctor along with the scans.

  • FGFR2 fusion. Seen mostly in cancers inside the liver. Tablets that block this change are used after the first chemotherapy.
  • IDH1 change. Also mostly inside the liver. A tablet that blocks it can slow the cancer.
  • HER2 high. More common in gallbladder cancer. Medicines aimed at HER2 are used in some countries.
  • MSI-high or BRAF change. These are uncommon, but when present, a different medicine is chosen.

Ask that the tissue block from your biopsy is kept and sent for a full gene panel. If tissue is too little, a blood version can be tried. A result of no change is also useful, as it tells the team that chemotherapy remains the path.

What does immune medicine add to chemotherapy?

Adding an immune medicine to gemcitabine and cisplatin helps some people live longer than chemotherapy alone, and is now part of usual first treatment.

Immune medicines help the body see the cancer. Trials of two such medicines, given with the usual two-drug chemotherapy, showed a gain in survival over chemotherapy alone. The extra drug is given by drip, usually on the same day.

The gain is real but modest, and side effects need watching. The immune system can inflame the skin, gut, liver or thyroid. Report diarrhoea, rash, new cough or yellowing early, because these are treated well when caught early.

What is given after surgery?

Capecitabine tablets for about six months are still the standard after surgery. Trials are asking whether stronger plans work better, and results are awaited.

After an operation that removes the cancer, capecitabine lowers the chance that it returns. It is taken at home in cycles. Several trials are now testing other plans, such as gemcitabine with cisplatin, or adding an immune medicine or a targeted drug in those with a matching gene change.

Until those results are out, capecitabine remains the advice. If a trial is open near you and you fit its rules, your cancer doctor may suggest joining. Joining is a choice, and you can step out at any time.

Can chemotherapy before surgery help?

For large gallbladder cancers that look hard to remove, chemotherapy first is being tested. It is not yet routine, and the decision is made case by case.

Many gallbladder cancers are found late, after an operation for stones, or when they are already large. Some Indian and Western trials are testing chemotherapy first, so the tumour shrinks and an operation becomes possible. Only those whose cancer responds go on to surgery.

  • Possible gain. Some tumours that could not be removed become removable.
  • Possible harm. A cancer that grows during chemotherapy may lose the chance of surgery.
  • Who decides. A team of surgeon, cancer doctor and radiologist, using the scan.

If the cancer is clearly removable now, waiting for chemotherapy first is not advised outside a trial.

What about blood tests and new surgery tools?

Blood tests for tumour DNA and better imaging during surgery are promising, but they are still being studied. They do not yet change standard advice.

A blood test can sometimes find tiny bits of tumour DNA after an operation. Researchers want to learn whether this can show who needs extra treatment. For now it is a research tool, so it should not be used alone to decide on more chemotherapy.

In the operating room, a green dye with a special camera helps show the bile ducts, and 3D models from the scan help plan how much liver to remove. Dr Harsh Shah does these operations by keyhole or open surgery, and does not use a robot.

What does this mean for you?

Ask for a tumour gene test, keep your tissue block, and see a team that offers surgery first when it is possible. Do not chase a new medicine in place of a safe operation.

  • Ask whether your cancer can be removed before talking of any new medicine.
  • Ask that the biopsy tissue is kept for a gene panel, and who will read it.
  • Ask if an immune medicine is part of your first chemotherapy plan.
  • Ask about trials only after you understand the usual plan.
  • Bring all reports and scan films, not only the summaries.

Frequently asked questions

Is there a new treatment for bile duct cancer?

Yes, in two ways. An immune medicine is now added to the usual chemotherapy, and tumour tests can find a change that a targeted tablet can act on. Surgery stays the main treatment whenever the cancer can be removed.

What tests should be done on the tumour?

Ask for a panel that looks at HER2, FGFR2, IDH1, BRAF and MSI status. It is done on the biopsy or operation tissue. A blood version exists for those whose tissue is too little.

Does a new medicine replace surgery?

No. A medicine cannot take the place of a clean operation when the cancer can be removed. The new medicines help when surgery is not possible, or when the cancer returns.

What is given after surgery for bile duct cancer?

Capecitabine tablets for about six months remain the standard. Trials are comparing stronger plans, and the results are awaited. Your cancer doctor will tell you if the advice changes.

Is chemotherapy before surgery used for gallbladder cancer?

It is being tested in trials, mainly for large tumours that look hard to remove. It is not yet the routine for everyone. Your surgeon and cancer doctor decide together.

Can a blood test show if the cancer will return?

Blood tests that look for tumour DNA are still under study. They are not yet used to decide treatment, so do not pay for one on its own without advice.

Are the new medicines easy to get in India?

Availability and cost vary, and some are given only through trials or access programmes. Ask your cancer doctor which medicine suits your tumour test, and what is available to you.

Related pages

For the full picture of these cancers and their care, start at the biliary tract cancer treatment page. For the cancer that sits at the liver gate, see perihilar cholangiocarcinoma treatment. For questions before you travel, call +91-63555-64601.

Where Dr Harsh Shah sees patients and operates

Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601

Read about new medicines for bile duct or gallbladder cancer and wondering what applies to you? Some are proven, some are still being tested, and none suits everyone. Dr Harsh Shah, a liver and gastro surgeon in Ahmedabad, reviews your reports and your tumour tests, and explains in plain words what is worth doing now. Bring every report, scan film and biopsy slide. You can also call us or write on WhatsApp. Call For Appointment Book on WhatsApp Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Get health updates from Dr Harsh Shah on WhatsApp

Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

Dr. Harsh J Shah
Dr Harsh Shah, Gastro, Cancer & Laparoscopic Surgeon, Ahmedabad
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.